Clinical trial

Droplet-BC Screening Test for the Detection of Breast Cancer, the DROPLET-BC Study

NCT04671498

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

PROCEDURE · Unmapped registry intervention Biospecimen Collection Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Droplet-BC Test Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Electronic Health Record Review Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Droplet-BC Screening Test for the Detection of Breast Cancer, the DROPLET-BC Study

Design: OBSERVATIONAL · Status: UNKNOWN · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2020-11-03

PhaseN/A

Conditions

Breast Carcinomaverified · MONDO: breast carcinoma

Interventions

Biospecimen CollectionPROCEDURE

Droplet-BC TestPROCEDURE

Electronic Health Record ReviewOTHER

Sponsors & collaborators

Preferred Medicine, Inclead sponsor

M.D. Anderson Cancer Centercollaborator

Mapped research locations

HoustonTexas, United States1 ChicagoIllinois, United States1 BuffaloNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04671498 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.